Disease-modifying antirheumatic drugs and organising pneumonia

Mohamed Faisal1, Asyraf Roslan1, Nik Nuratiqah Nik Abeed1

  • 1Respiratory Unit, Department of Medicine, Faculty of Medicine, Universiti Kebangsaan Malaysia Medical Centre, Cheras, Kuala Lumpur, Malaysia.

BMJ Case Reports
|January 7, 2021
PubMed

Insights

Rheumatoid arthritis patients can develop organizing pneumonia (OP) due to medications like methotrexate and leflunomide. Early diagnosis and treatment with corticosteroids lead to recovery.

Area of Science:

  • Rheumatology
  • Pulmonology
  • Pharmacology

Background:

  • Organizing pneumonia (OP) in rheumatoid arthritis (RA) can be disease-related or drug-induced.
  • Disease-modifying antirheumatic drugs (DMARDs) are commonly used to manage RA.
  • Identifying drug-related pulmonary complications is crucial for patient management.

Observation:

  • A case series of two RA patients experiencing OP attributed to DMARDs.
  • Patient 1 developed OP 3 weeks after starting methotrexate (MTX).
  • Patient 2 developed OP while on MTX and leflunomide.

Findings:

  • High-resolution CT (HRCT) scans showed bilateral consolidations in one patient and left upper lobe consolidation in the other.
  • Both patients achieved complete radiological and clinical resolution with corticosteroid therapy and drug cessation/modification.
  • OP can occur with low-dose methotrexate and leflunomide, even early in treatment.

Implications:

  • This case series underscores the importance of considering drug-induced OP in RA patients presenting with pulmonary symptoms.
  • A high index of suspicion is necessary for timely diagnosis and effective management.
  • Understanding the potential pulmonary side effects of RA medications is vital for clinicians.

Related Concept Videos

Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
3.0K
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
126
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
136
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
589
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
2.9K
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
830